Chikungunya encephalitis: report of a fatal case in Northeastern Brazil by Lima, Elaine Cristina Bomfim de et al.
Rev Inst Med Trop São Paulo. 2020;62:e40 Page 1 of 5
CASE REPORT
http://doi.org/10.1590/S1678-9946202062040
This is an open-access article distributed under the 
terms of the Creative Commons Attribution License.
1Universidade Federal de Pernambuco, 
Programa de Pós Graduação em Medicina 
Tropical, Recife, Pernambuco, Brazil
2Secretaria de Saúde do Estado de 
Pernambuco, Hospital Correia Picanço, 
Recife, Pernambuco, Brazil
3Universidade Federal de Pernambuco, 
Departamento de Medicina Clínica, Recife, 
Pernambuco, Brazil
Correspondence to: Elaine Cristina 
Bomfim de Lima 
Universidade Federal de Pernambuco, 
Programa de Pós Graduação em Medicina 
Tropical, Hospital das Clínicas, Bloco A 
Térreo, Av. Prof. Moraes Rego, s/n, Cidade 
Universitária, CEP 50670-901, Recife, PE, 
Brazil
E-mail: lainebomf@gmail.com
Received: 13 April 2020
Accepted: 16 May 2020
Chikungunya encephalitis: report of a fatal case in 
Northeastern Brazil
Elaine Cristina Bomfim de Lima 1, Alexandre Medeiros Sampaio Januário2, 
Eliane Guimarães Fortuna2, Maria Eulália Corte Real2, Heloísa Ramos 
Lacerda1,3
ABSTRACT
Chikungunya, a viral infection that presents with fever, rash and polyarthritis, is usually 
an acute febrile illness. Uncommon neurological manifestations include meningoencephalitis, 
encephalitis, myelitis, Guillain-Barre syndrome, myelopathy and neuropathy. During 
an outbreak of the disease in La Reunion Island, abnormalities were observed in the 
magnetic resonance imaging (MRI) of patients with encephalitis and acute disseminated 
encephalomyelitis, showing bilateral, frontoparietal, white matter lesions with restricted 
diffusion, similar to our case. We report a 57-year-old male patient with comorbidities, 
admitted with high fever, arthralgia, asthenia, vomiting, psychomotor agitation, behavioral 
changes and seizures. Cerebrospinal fluid (CSF) values  revealed pleocytosis (98 cells/mm3 
with 68% lymphocytes and 12% monocytes) and high levels of protein (161 mg%). Brain 
MRI showed hyperintense lesions in the temporal and frontal lobes and bilaterally in the 
posterior thalamus. CSF serology was positive for IgM antibodies to Chikungunya virus. 
Encephalitis due to an acute viral infection by Chikungunya was diagnosed. The patient’s 
clinical condition worsened and he died on the twenty-fourth day of admission to our hospital.
KEYWORDS: Chikungunya encephalitis. Neurological manifestations. Magnetic resonance 
imaging. Fatal cases. 
INTRODUCTION
Chikungunya virus (CHIKV) belongs to the Alphavirus genus, which is a 
member of the Togaviridae family. Although neuro-chikungunya is relatively 
infrequent, there has been a recent increase in reports of such complications, due 
to a number of people infected across three continents during the 2004–2009 
outbreaks. CHIKV seems to target ependymal cells, progenitor and stem cells in 
the subventricular zone. This impairs neurogenesis and neuronal migration, and is 
a hypothesis for the neuropathogenesis of encephalomyelitis related to CHIKV1. 
The literature presents many reports of dengue and Zika cases, which seek to 
explain the association between neurological and arboviral findings, clinical aspects, 
laboratory diagnosis and patients’ evolution. However, few studies have addressed 
the association with neurological deficit using the detection of antibodies raised to the 
virus in cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI)2,3. In the 
literature review, we found case reports in several different locations. In India, two 
cases were reported with clinical and neuroimaging findings and one case with brain 
autopsy findings of encephalomyeloradiculitis from CHIKV, a relatively unknown 
and rare complication of the infection. The neuroimaging findings were bilateral 
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frontoparietal white matter lesions with restricted diffusion, 
which are described as early signs of viral encephalitis. 
These patients were infected during an epidemic in an 
endemic zone of Eastern Maharashtra, India1. In a study by 
Chandak et al.4 on neurological complications, encephalitis 
was the most common syndrome presented in 55% of 
patients. In this series, the neuropathy was a predominantly 
demyelination. Magnetic Resonance Imaging (MRI) 
presented signal changes in the spinal cord suggestive of 
a demyelination pathology in only three of the 14 patients 
with myelopathy/myeloneuropathy. In a case series study 
conducted in Brazil, one significant finding was that four 
patients with evidence of Zika virus (ZIKV) infection also 
presented with central nervous system infection caused 
by CHIKV. Ten further patients, who were negative for 
Zika virus, tested positive for chikungunya virus. In South 
America, reports of neurological disease associated with 
CHIKV are scarce, which may reflect a lack of awareness 
amongst clinicians regarding the potential of the virus to 
affect the nervous system, or the relatively recent arrival of 
the virus. It is interesting that, in our patient, the virus was 
detected 30 days after the onset of the neurological disease, 
suggesting a persistent infection or a late coincidental 
infection3. In summary, these studies have demonstrated 
the growing evidence that a broad spectrum of neurological 
diseases is associated with arboviruses infections. One 
important finding is that some patients suspected of having 
a neurological disorder associated with Zika virus were 
infected by CHIKV, and many were infected with more 
than one arbovirus.
CASE REPORT
A 57-year-old male agricultural worker with a history 
of type 2 diabetes and arterial hypertension, presented 
with high-grade fever, arthralgia, asthenia and vomiting 
during the eight days prior to admission to our hospital. 
On the 8th day, he presented with psychomotor agitation, 
behavioral changes and seizures. A computed tomography 
(CT) brain scan without contrast was performed and had 
no abnormalities. CSF analysis presented neutrophilia 
(72%) pleocytosis (240 cells/mm3) with normal glucose 
and high protein levels. Because of the neurological 
deterioration, the patient was admitted to our hospital. On 
admission, hypotension, bradycardia and a reduced level 
of conscience was observed (Glasgow coma scale 11). On 
the same day, the patient presented severe dyspnea and was 
promptly intubated. He received mechanical ventilation and 
continuous sedation. One-gram ceftriaxone and antiepileptic 
drugs were initiated. Laboratory tests revealed renal 
dysfunction, but conservative treatment (no hemodialysis) 
was maintained. On the second day, the antimicrobial 
therapy was modified to include one-gram of ampicillin and 
250 mg of acyclovir. A brain MRI revealed frontal, parietal 
and mesial bilateral temporal cortical and subcortical altered 
signals with restricted diffusion and similar abnormalities 
in the posterior thalamus, midbrain and cerebellar vermis, 
and no enhancement was noted. These findings were 
compatible with a diffuse encephalitis. Further CSF analysis 
(day 12 of the disease) revealed pleocytosis (98 cells/mm3 
with 68% of lymphocytes and 12% of monocytes), 
high protein (161 mg%), normal glucose (81 mg%) 
and high adenosine deaminase level (47.9 international 
units (UI)/L, normal < 4.5 UI/L). Negative results were 
obtained for syphilis and the human immunodeficiency 
virus (HIV) antibodies and polymerase chain reaction for 
Mycobacterium tuberculosis, herpes virus types 1 and 2 were 
carried out. CSF and serum were positive for IgM antibodies 
to CHIKV (using the IgM antibody capture ELISA 
[MAC-ELISA]5 and commercial ELISA [Euroimmun, 
Lübeck, Schleswig-Holstein, Germany], respectively). 
A clinical deterioration of the patient was identified 
and despite the absence of sedative drugs, he remained 
in a coma and died on day 24 after onset of the illness.
DISCUSSION 
In most cases, the damage caused by CHIKV has a 
self-limiting course with nonspecific symptoms, similar 
to dengue fever and including headache, joint pain and 
weakness. The characteristic clinical manifestations of 
CHIKV are intense joint pain and arthritis6. Fatality usually 
occurs in patients with associated comorbidities and aging, 
as in the case of our patient. The involvement of the nervous 
system is not uncommon in arboviral infections, and 
CHIKV belongs to the alphavirus genera, of which some 
members are known to be neurotropic7. This study reports a 
fatal case of CHIKV associated with encephalitis using the 
findings from both, CSF analysis and brain MRI. There were 
similar clinical characteristics and neuroimaging features of 
encephalitis and acute disseminated encephalomyelitis, with 
bilateral frontoparietal white matter lesions with restricted 
diffusion, as previously described during an outbreak of 
the disease on La Reunion Island6,8. Another case report 
of encephalitis associated with CHIKV described two 
patients from Thailand with neurological manifestations: 
seizures, behavioral changes and motor dysfunction as 
in our patient. However, there was no fatal outcome9. 
As presented in Figure 1, our patient presented notable 
hyperintense lesions in the temporal and frontal lobes 
and bilaterally in the posterior thalamus in the diffusion 
weighted imaging (DWI) sequences. This MRI appearance 
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using DWI is closely related to the pathologic changes 
(cytotoxic edema) that occur following a viral invasion. 
The most important differential diagnosis of these lesions 
(Figure 1) in our patient is the epileptic status, which 
probably occurred during the first days of hospitalization. 
In the epileptic status, neuronal injury results primarily 
from an excitotoxic mechanism mediated by the intrinsic 
neuronal seizure activity. During the epileptic status, 
the neuronal seizure activity increases the release of 
glutamate from the presynaptic terminals of neuronal axons. 
Excessive glutamate crosses the synaptic cleft to bind with 
N-methyl-D-aspartate (NMDA) and non-NMDA receptors, 
which causes cytotoxic edema in the neurons and glial 
cells, leading to apoptosis or selective neuronal necrosis. 
Astrocytes play an important role in cellular and tissue 
repair by detoxifying excessive glutamate. It is presumed 
that the cytotoxic edema of reactive astrocytes in the acute 
phase is responsible for the reversible abnormalities of 
the signal intensity. Encephalopathy with epileptic status 
often involves the hippocampus, other parts of the limbic 
system, the thalamus, and the cerebellum. This distribution 
of lesions in DWI seems to be related to the distribution of 
NMDA-type glutamate receptors, which are concentrated 
in the hippocampus and in other parts of the limbic system7. 
Our patient presented with a different pattern of lesion 
distribution, raising the possibility of encephalitis-related 
abnormalities. In acute viral encephalitis, concentrations of 
glutamate and glycine in the CSF are significantly increased. 
This observation suggests that an excitotoxic mechanism 
plays a role in neuronal damage. Excessive glutamate 
release, due to free radicals generated during the immune 
response to infections, might initiate the excitotoxicity. 
The areas usually affected are the medial temporal lobes, 
the inferior frontal lobes and the insula7. In our patient, 
it does not determine the origin of the IgM detected in 
the CSF, whether synthesized in the CSF itself or derived 
from blood, reaching the CSF through the damaged blood-
brain barrier. However, the systemic, epidemiological, and 
serological conditions support the diagnosis of acute CHIK 
infection and the neurological condition, secondary to its 
Figure 1 - Magnetic resonance imaging showing lesions in the temporal and frontal lobes of the patient. Axial diffusion-weighted 
images (a, b, c), FLAIR (d, e, f) and T1 with gadolinium (g, h, i) demonstrate bilateral hyperintensities in the medial temporal and 
frontal lobes and the posterior thalami with similar but less intense abnormalities in the FLAIR sequences and no enhancement 
after gadolinium administration.
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complication. There are no definitive studies on the origin 
of IgM antibodies against CHIK detected in the CSF10,11, 
but the detection of viral RNA and the alteration found in 
the CSF suggest a neurotropic action of CHIKV12,13. A case 
report demonstrated the intrathecal synthesis of antibodies 
to CHIK in a patient with encephalitis, using the specific 
index of IgG antibodies in the CSF. The authors suggested 
that this finding associated with the clinical situation is 
the basis for diagnosing encephalitis caused by CHIKV14.
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